Thomas Chi, MD
Urology · Birmingham, ALNPI 1245360320
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $338,436 of the $463,287 with a category attached, or 73.1%. Johnson & Johnson accounts for 61.8% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $228,742 and has fallen 82.6% since, to $39,881 in 2025. Among urology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $2049.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$286K
- Boston Scientific$97K
- Cook Incorporated$39K
- C. R. Bard, Inc. & Subsidiaries$12K
- Calyxo, Inc.$10K
- Alnylam Pharmaceuticals Inc.$9K
- plus $10K from 11 others
Across 29 payments — averaging $6433.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$101K
- Alnylam Pharmaceuticals Inc.$64K
- Calyxo, Inc.$22K
What the payments were for
- Consulting fees$97,31421%
- Speaking & faculty fees$338,43673%
- Travel & lodging$19,8624%
- Food & beverage$6,9271%
- Education$5000%
- Entertainment$2480%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 39 | $286,191 |
| Boston Scientific | 110 | $96,911 |
| Cook Incorporated | 19 | $39,055 |
| C. R. Bard, Inc. & Subsidiaries | 11 | $11,839 |
| Calyxo, Inc. | 14 | $10,226 |
| Alnylam Pharmaceuticals Inc. | 4 | $8,573 |
| Micro-tech Endoscopy USA, Inc. | 2 | $2,250 |
| Medical Device Business Services, Inc. | 5 | $2,097 |
| Richard Wolf Medical Instruments Corp. | 3 | $2,067 |
| Uromedica, Incorporated | 4 | $1,832 |
| Cook Medical LLC | 7 | $1,557 |
| Hitachi Healthcare Americas Corp. | 3 | $248 |
| Olympus America Inc. | 1 | $136 |
| Novo Nordisk | 1 | $125 |
| Medtronic | 1 | $119 |
| Procept Biorobotics Corporation | 1 | $47 |
| Urogen Pharma, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL KIDNEY STONE DISEASE$51,192
- Monarch Platform$27,458
- S~Curve$20,583
- LithoVue$18,542
- MONARCH$14,047
- Cook$11,470
- GENERAL - THERAPIES$9,447
- Lumenis Pulse 120H$8,945
- CVAC Aspiration System$7,892
- Cook Medical Dilation/Access$3,920
- OXLUMO$3,780
- GIVLAARI$3,780
- FIBER DUST$2,889
- CVAC$2,238
- ProACT$1,832
- All Products$1,750
- Cook Medical Urology$1,470
- Bard Urinary Drainage Bag$560
- THERAPIES$164
- Moses$141
How this compares
$463,287 in reported general payments places this provider in the 95th percentile of 179 urology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 62 | $46,605 |
| GemtesaVibegron | 21 | $21,983 |
| Tadalafil | 51 | $10,667 |
| Trospium Chloride ErTrospium Chloride | 17 | $4,532 |
| Potassium Citrate ErPotassium Citrate | 28 | $4,327 |
| Tamsulosin Hcl | 117 | $1,508 |
| Oxybutynin Chloride ErOxybutynin Chloride | 35 | $954 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 45 | $889 |
| Silodosin | 13 | $805 |
| Trospium Chloride | 15 | $656 |
| Finasteride | 62 | $554 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $219 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $69 |
| NitrofurantoinNitrofurantoin Macrocrystal | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Other urology in Birmingham
- Joel FunkBirmingham$347K
- Adam BaumgartenBirmingham$271K
- Kyle WoodBirmingham$91K
- Jeffrey NixBirmingham$54K
- Tracey WilsonBirmingham$38K
- Charles PeytonBirmingham$27K
- Kazumi TaguchiBirmingham$19K
- Andrew FangBirmingham$5K
- Kyle GennaroBirmingham$5K
- Brian ChristineHomewood$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.